Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Open House Pharmaceutical Discount Contracts For The Active Ingredient Fentanyl, Only Sublingual Tablets, Lozenges Or Nasal Spray, Atc N02ab03 2026-09-13
Finland Diagnostic Devices And Accessories Dps 2026-09-13
Germany Open House Pharmaceutical Discount Contracts For The Active Ingredient Tolvaptan, Atc G04bx21 2026-09-13
Germany Open House Pharmaceutical Discount Contracts For The Active Ingredient Eptinezumab, Atc N02cd05 2026-09-13
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Moxifloxacin, Atc S01ae07 For The Period 01.05.26 To 30.04.28 (plus Option For 1x12 Months) 2026-09-13
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Enalapril (without 2.5 Mg + 5 Mg), Atc C09aa02 For The Period 01.05.26 To 30.04.28 (plus Option For 1x12 Months) 2026-09-13
Germany Open House Pharmaceutical Discount Contracts Eptinezumab, Atc N02cd05 2026-09-13
Germany Open House Original Discount Contracts 202602 Ponatinib 2026-09-13
Germany Open House Drug Discount Contracts For The Active Ingredient Pimecrolimus, Atc D11ah02 2026-09-13
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Pimecrolimus, Atc D11ah02 For The Period 01.05.26 To 30.04.28 (plus Option For 1x12 Months) 2026-09-13
Whats app